New treatments for pulmonary fibrosis?
Egan
J J
JJ
North West Lung Centre, Wythenshawe Hospital, Manchester, UK.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000188:drug therapy* / Q000473:pathology; D011994:Recombinant Proteins; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D014665:Vasodilator Agents; D007371:Interferon-gamma; D011464:Epoprostenol; D016285:Iloprost